Source: PR Newswire

Press Release: STIVARGA : Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer

WHIPPANY, N.J., June 19, 2019 /PRNewswire/ -- Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with newly diagnosed and recurrent glioblastoma, the...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



STIVARGA's headquarters is in Whippany, New Jersey. STIVARGA has a revenue of $10M, and 10 employees.